Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Ilex and LeukoSite form joint venture for development of Campath-1H

May 14, 1997

Ono-4007 restores immune responses in tumor-bearing animals

May 12, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Chiron and Biomira enter partnership for Theratope cancer vaccine

May 8, 1997

Immunomedics files IND for humanized lymphoma antibody

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...